Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ludwig

Showing results (311-320 of 500) with videos related to

Pageof 50
Sort By:
Pathologie-Biologie|November 1, 1992
GM-CSF in the treatment of acute myeloid leukemiaW Hiddemann, G Maschmeyer, W D Ludwig, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Immunophenotype of acute myeloid leukemia: correlation with morphological characteristics and therapy responseC Sperling, H Seibt-Jung, W Gassmann, et al.
Blood|September 1, 1991
Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapseT Büchner, W Hiddemann, M Koenigsmann, et al.
Onkologie|February 1, 1989
Age related randomized comparison of sequentially applied high-dose versus intermediate dose cytosine arabinoside in combination with mitoxantrone (S-HAM) in the treatment of relapsed and refractory acute myeloid leukemia: study design and preliminary resultsW Hiddemann, C Aul, G Maschmeyer, et al.
Haematologica|December 20, 1999
Impact of immunophenotyping on management of acute leukemiasM C Béné, M Bernier, G Castoldi, et al.
Leukemia|September 20, 2000
Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivoA Prokop, T Wieder, I Sturm, et al.
Zentralblatt Fur Chirurgie|January 6, 2001
[Ulcerative colitis-associated colorectal carcinoma. DNA ploidy as indicator of impending malignant transformation?]H Schimmelpenning, J Habermann, S Krüger, et al.
Seminars in Hematology|July 1, 1991
High-dose versus intermediate-dose cytarabine combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age-adjusted randomized comparisonW Hiddemann, C Aul, G Maschmeyer, et al.
Leukemia|January 1, 1992
Longterm effects of prolonged maintenance and of very early intensification chemotherapy in AML: data from AMLCGT Büchner, W Hiddemann, B Wörmann, et al.
Environmental Science & Technology|April 17, 2009
Treatment of arsenic, heavy metals, and acidity using a mixed ZVI-compost PRBRalph D Ludwig, David J A Smyth, David W Blowes, et al.
Pageof 50

Showing results (311-320 of 500) with videos related to

Sort By:
Pageof 50
Pathologie-Biologie|November 1, 1992
GM-CSF in the treatment of acute myeloid leukemiaW Hiddemann, G Maschmeyer, W D Ludwig, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Immunophenotype of acute myeloid leukemia: correlation with morphological characteristics and therapy responseC Sperling, H Seibt-Jung, W Gassmann, et al.
Blood|September 1, 1991
Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapseT Büchner, W Hiddemann, M Koenigsmann, et al.
Onkologie|February 1, 1989
Age related randomized comparison of sequentially applied high-dose versus intermediate dose cytosine arabinoside in combination with mitoxantrone (S-HAM) in the treatment of relapsed and refractory acute myeloid leukemia: study design and preliminary resultsW Hiddemann, C Aul, G Maschmeyer, et al.
Haematologica|December 20, 1999
Impact of immunophenotyping on management of acute leukemiasM C Béné, M Bernier, G Castoldi, et al.
Leukemia|September 20, 2000
Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivoA Prokop, T Wieder, I Sturm, et al.
Zentralblatt Fur Chirurgie|January 6, 2001
[Ulcerative colitis-associated colorectal carcinoma. DNA ploidy as indicator of impending malignant transformation?]H Schimmelpenning, J Habermann, S Krüger, et al.
Seminars in Hematology|July 1, 1991
High-dose versus intermediate-dose cytarabine combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age-adjusted randomized comparisonW Hiddemann, C Aul, G Maschmeyer, et al.
Leukemia|January 1, 1992
Longterm effects of prolonged maintenance and of very early intensification chemotherapy in AML: data from AMLCGT Büchner, W Hiddemann, B Wörmann, et al.
Environmental Science & Technology|April 17, 2009
Treatment of arsenic, heavy metals, and acidity using a mixed ZVI-compost PRBRalph D Ludwig, David J A Smyth, David W Blowes, et al.
Pageof 50